Effects of removing reimbursement restrictions on targeted therapy accessibility for non-small cell lung cancer treatment in Taiwan: an interrupted time series study by Jason C Hsu, Chen-Fang Wei, Szu-Chun Yang

Get full text

Considering lead-time bias in evaluating the effectiveness of lung cancer screening with real-world data by Szu-Chun Yang, Jung-Der Wang, Shi-Yi Wang

Get full text

Cost-Effectiveness of Nivolumab Plus Ipilimumab With and Without Chemotherapy for Advanced Non-Small Cell Lung Cancer by Szu-Chun Yang, Szu-Chun Yang, Natalia Kunst, Natalia Kunst, Natalia Kunst, Cary P. Gross, Jung-Der Wang, Wu-Chou Su, Shi-Yi Wang, Shi-Yi Wang

Get full text

Cost‐effectiveness of first‐line immunotherapies for advanced non‐small cell lung cancer by Szu‐Chun Yang, Huang‐Tz Ou, Wu‐Chou Su, Shi‐Yi Wang

Get full text

Cost-effectiveness of lazertinib as first-line treatment in patients with -mutated advanced lung cancer by Li-Jung Elizabeth Ku, Jui-Hung Tsai, Li-Jun Chen, Szu-Chun Yang

Get full text

Effective prevention in clinical practice may save human capital loss: Real-world evidence from Taiwan's National Health Insurance by Fuhmei Wang, Wen-Yen Huang, Yu-Tzu Chang, Szu-Chun Yang, Jung-Der Wang

Get full text

Economic Analysis of Tissue-First, Plasma-First, and Complementary NGS Approaches for Treatment-Naïve Metastatic Lung Adenocarcinoma by Szu-Chun Yang, Chien-Chung Lin, Yi-Lin Chen, Yi-Lin Chen, Wu-Chou Su

Get full text

Comparative effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in Taiwan. by Szu-Chun Yang, Wu-Wei Lai, Jason C Hsu, Wu-Chou Su, Jung-Der Wang

Get full text

Estimation of disability free life expectancy in non small cell lung cancer based on real world data by Shin-Mao Lin, Szu-Chun Yang, Tzu-I. Wu, Jung-Der Wang, Li-Fan Liu

Get full text

Estimating Taiwan's QALY league table for catastrophic illnesses: Providing real-world evidence to integrate prevention with treatment for resources allocation by Jung-Der Wang, Wu-Wei Lai, Szu-Chun Yang, Wen-Yen Huang, Jing-Shiang Hwang

Get full text

Typical antipsychotics is associated with increased risk of severe exacerbation in asthma patients: a nationwide population-based cohort study by Chin-Wei Kuo, Szu-Chun Yang, Yu-Fen Shih, Xin-Min Liao, Sheng-Hsiang Lin

Get full text

Indigenous recurrent disseminated histoplasmosis in Taiwan by Hung-I Kuo, Xin-Min Liao, Szu-Chun Yang, Jen-Chieh Lee, Kung-Chao Chang, Cong-Tat Cia

Get full text

Lung cancer survival and mortality in Taiwan following the initial launch of targeted therapies: an interrupted time series study by Jason C Hsu, Chen-Fang Wei, Szu-Chun Yang, Peng-Chan Lin, Yang-Cheng Lee, Christine Y Lu

Get full text

Multiple in-hospital counseling increases six-month smoking abstinence among individuals participating in a hospital-initiated smoking cessation program by Chin-Wei Kuo, Chuan-Yu Chen, Chih-Hsing Wu, Chang-Wen Chen, Fei-Ran Guo, Szu-Chun Yang

Get full text

The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis. by Wei-Yuan Chang, Yi-Lin Wu, Po-Lan Su, Szu-Chun Yang, Chien-Chung Lin, Wu-Chou Su

Get full text

Dynamic changes in quality of life after three first-line therapies for EGFR mutation-positive advanced non-small-cell lung cancer by Szu-Chun Yang, Chien-Chung Lin, Wu-Wei Lai, Sheng-Mao Chang, Jing-Shiang Hwang, Wu-Chou Su, Jung-Der Wang

Get full text

Estimating time and transportation costs associated with lung cancer screening and diagnostic lung procedures in Taiwan: a cross-sectional survey in a medical centre by Szu-Chun Yang, Chien-Yu Lin, Ting-Hsing Chao, Chi-Hao Wu, Li-Jung Elizabeth Ku, Ta-Jung Chung, Hui-Ju Liu

Get full text

Pembrolizumab and Chemotherapy Combination Prolonged Progression-Free Survival in Patients with NSCLC with High PD-L1 Expression and Low Neutrophil-to-Lymphocyte Ratio by Jeng-Shiuan Tsai, Sheng-Huan Wei, Chian-Wei Chen, Szu-Chun Yang, Yau-Lin Tseng, Po-Lan Su, Chien-Chung Lin, Wu-Chou Su

Get full text

Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer by Po-Lan Su, Yi-Lin Wu, Wei-Yuan Chang, Chung-Liang Ho, Yau-Lin Tseng, Wu-Wei Lai, Wu-Chou Su, Chien-Chung Lin, Szu-Chun Yang

Get full text

EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysis by Jeng-Shiuan Tsai, Po-Lan Su, Szu-Chun Yang, Chao-Chun Chang, Chia-Ying Lin, Yi-Ting Yen, Yau-Lin Tseng, Wu-Wei Lai, Chien-Chung Lin, Wu-Chou Su

Get full text